← Back to Search
Prediction Of Individual Genetic Risk To Disease From Genome-wide Association Studies.
N. Wray, M. Goddard, P. Visscher
Published 2007 · Biology, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Empirical studies suggest that the effect sizes of individual causal risk alleles underlying complex genetic diseases are small, with most genotype relative risks in the range of 1.1-2.0. Although the increased risk of disease for a carrier is small for any single locus, knowledge of multiple-risk alleles throughout the genome could allow the identification of individuals that are at high risk. In this study, we investigate the number and effect size of risk loci that underlie complex disease constrained by the disease parameters of prevalence and heritability. Then we quantify the value of prediction of genetic risk to disease using a range of realistic combinations of the number, size, and distribution of risk effects that underlie complex diseases. We propose an approach to assess the genetic risk of a disease in healthy individuals, based on dense genome-wide SNP panels. We test this approach using simulation. When the number of loci contributing to the disease is >50, a large case-control study is needed to identify a set of risk loci for use in predicting the disease risk of healthy people not included in the case-control study. For diseases controlled by 1000 loci of mean relative risk of only 1.04, a case-control study with 10,000 cases and controls can lead to selection of approximately 75 loci that explain >50% of the genetic variance. The 5% of people with the highest predicted risk are three to seven times more likely to suffer the disease than the population average, depending on heritability and disease prevalence. Whether an individual with known genetic risk develops the disease depends on known and unknown environmental factors.
This paper references
Introduction to Quantitative Genetics
D. Falconer (1960)
Linkage strategies for genetically complex traits. I. Multilocus models.
N. Risch (1990)
Genetics and Analysis of Quantitative Traits
M. Lynch (1996)
The Future of Genetic Studies of Complex Human Diseases
N. Risch (1996)
Population genetics—making sense out of sequence
A. Chakravarti (1999)
Are rare variants responsible for susceptibility to complex diseases?
J. Pritchard (2001)
Prediction of total genetic value using genome-wide dense marker maps.
T. Meuwissen (2001)
On the allelic spectrum of human disease.
David E. Reich (2001)
Multifactorial genetics: Understanding quantitative genetic variation
N. Barton (2002)
Diagnosis of multiple cancer types by shrunken centroids of gene expression
R. Tibshirani (2002)
Polygenic susceptibility to breast cancer and implications for prevention
P. Pharoah (2002)
Understanding quantitative genetic variation
P. D. Keightley (2002)
A vision for the future of genomics research
F. Collins (2003)
Large-scale genotyping of complex DNA
G. Kennedy (2003)
Statistical significance for genomewide studies
John D. Storey (2003)
Predicting disease using genomics
J. Bell (2004)
Mapping complex disease loci in whole-genome association studies
C. Carlson (2004)
An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions
M. Khoury (2004)
QTL Analysis of Multiple Behavioral Measures of Anxiety in Mice
Norman D. Henderson (2004)
The genetic architecture of quantitative traits: lessons from Drosophila.
T. Mackay (2004)
Genome-wide association studies for common diseases and complex traits
J. Hirschhorn (2005)
How many genes underlie the occurrence of common complex diseases in the population?
Q. Yang (2005)
Genetic Prediction of Future Type 2 Diabetes
V. Lyssenko (2005)
Many QTLs with minor additive effects are associated with a large difference in growth between two selection lines in chickens.
L. Jacobsson (2005)
What is the clinical utility of genetic testing?
S. Grosse (2006)
Evaluating coverage of genome-wide association studies
J. Barrett (2006)
Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases.
J. Ioannidis (2006)
Quantifying the health benefits of genetic tests: The importance of a population perspective
M. Khoury (2006)
Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration
J. Maller (2006)
Should Industry Speak the Loudest in Informing the Public on Medical Matters ?
I. Read (2006)
Predictive testing for complex diseases using multiple genes: Fact or fiction?
A. Janssens (2006)
Genome-wide genetic association of complex traits in heterogeneous stock mice
W. Valdar (2006)
A common coding variant in CASP8 is associated with breast cancer risk
A. Cox (2007)
A genome-wide association study identifies novel risk loci for type 2 diabetes
R. Sladek (2007)
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
L. Bertram (2007)
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
E. Zeggini (2007)
Overcoming the winner's curse: estimating penetrance parameters from case-control data.
Sebastian Zollner (2007)
Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels
R. Saxena (2007)
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
P. Burton (2007)
A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants
L. Scott (2007)
The Wellcome Trust Case Control Consortium, U.K.
K. Mossman (2008)
This paper is referenced by
Educational attainment as a modifier of the effect of polygenic scores for cardiovascular risk factors: cross-sectional and prospective analysis of UK Biobank
Alice R Carter (2021)
The practical utility of genetic screening in school settings
J. Shero (2021)
Admixture Has Shaped Romani Genetic Diversity in Clinically Relevant Variants
N. Font-Porterias (2021)
Assessing Selection Bias in Regression Coefficients Estimated from Non- Probability Samples, with Applications to Genetics and Demographic Surveys
B. West (2021)
Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder
G. Fanelli (2021)
Genetic evidence for a large overlap and potential bidirectional causal effects between resilience and well-being
L.P. de Vries (2021)
A dimensional perspective on the genetics of obsessive-compulsive disorder
N. Strom (2021)
Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorder
C. Okhuijsen-Pfeifer (2021)
Phenotype risk scores (PheRS) for pancreatic cancer using time-stamped electronic health record data: Discovery and validation in two large biobanks
M. Salvatore (2021)
Genetic assessments of breast cancer risk that do not account for polygenic background are incomplete and lead to incorrect preventative strategies
G. Busby (2021)
Preliminary insights into the genetic architecture of postpartum depressive symptom severity using polygenic risk scores
Jennie G. Pouget (2021)
Can polygenic risk scores help identify pediatric bipolar spectrum and related disorders?: A systematic review
J. Biederman (2021)
Resource profile and user guide of the Polygenic Index Repository.
Joel Becker (2021)
Genetic interactions with stressful environments in depression and addiction
M. Burmeister (2021)
Genomic Risk Score for Melanoma in a Prospective Study of Older Individuals.
A. Bakshi (2021)
Statistical genetics and polygenic risk score for precision medicine
T. Konuma (2021)
Genetic Architecture of Depression: Where Do We Stand Now?
Pinar Unal-Aydin (2021)
Polygenic risk score for genetic evaluation of prostate cancer risk in Asian populations: A narrative review
S. Song (2021)
Genomic constraints to drought adaptation
Collin W. Ahrens (2021)
Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth
Yu-chung Lin (2021)
Genome-wide fine-mapping identifies pleiotropic and functional variants that predict many traits across global cattle populations.
R. Xiang (2021)
Childhood Socioeconomic Status and Polygenic Scores for Cognition Have Independent Associations with Cognitive Performance in Childhood
S. E. Paul (2021)
Precision Medicine for Obesity
Lizeth Cifuentes (2021)
Efficient verification for outsourced genome-wide association studies
Xinyu Wang (2021)
How does genetic variation modify ND-CNV phenotypes?
T. Dinneen (2021)
Resource Profile and User Guide of the Polygenic Index Repository
Joel Becker (2021)
A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts
G. Ni (2021)
Polygenic Scores for ADHD: A Meta-Analysis.
J. J. Li (2021)
Systematic Evaluation of Cross Population Polygenic Risk Score on Colorectal Cancer
Bharuno Mahesworo (2021)
Mental health dished up—the use of iPSC models in neuropsychiatric research
R. Mcneill (2020)
Searching Far and Genome-Wide: The Relevance of Association Studies in Amyotrophic Lateral Sclerosis
Kelly A Rich (2020)
A systematic review of gene-by-intervention studies of alcohol and other substance use.
Z. Neale (2020)See more